Evidence map›Paper›PMID 32958621›Full record

ArticleDiabetes care2020

Response to Comment on Misra et al. Homozygous Hypomorphic

Shivani Misra, Neelam Hassanali, Amanda J Bennett, Agata Juszczak, Richard Caswell, Kevin Colclough, Jonathan Valabhji, Sian Ellard, Nicholas S Oliver, Anna L Gloyn

Open access · bronzeAbstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Diabetes care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Shivani MisraDiabetes, Endocrinology & Metabolism, Imperial College London, London, U.K. s.misra@imperial.ac.uk.ORCID 0000-0003-2886-0726
Neelam HassanaliOxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, U.K.
Amanda J BennettOxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, U.K.
Agata JuszczakOxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, U.K.
Richard CaswellInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K.
Kevin ColcloughInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K.
Jonathan ValabhjiDiabetes and Endocrinology, Imperial College Healthcare NHS Trust, London, U.K.ORCID 0000-0001-9756-4061
Sian EllardInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, U.K.
Nicholas S OliverDiabetes, Endocrinology & Metabolism, Imperial College London, London, U.K.ORCID 0000-0003-3525-3633
Anna L GloynOxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, U.K.ORCID 0000-0003-1205-1844
Imperial College Healthcare NHS Trust · GBOxford Centre for Diabetes, Endocrinology and Metabolism · GBUniversity of Exeter · GBCentre for Human Genetics · GB

Funding

Wellcome Trust 095101Wellcome Trust 200837Wellcome Trust 200837/Z/16/Z
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes MellitusSulfonylurea CompoundsAllelesHepatocyte Nuclear Factor 1-alphaHumansHepatocyte Nuclear Factor 1-alphaHNF1A protein, humanSulfonylurea Compounds

Identifiers

PMID32958621
PMCPMC7510032
OpenAlexW3087344700

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.